Loading clinical trials...
Loading clinical trials...
A Phase 2, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Contezolid Acefosamil Compared to Linezolid Administered Intravenously and Orally to Adult Subjects With Acute Bacterial Skin and Skin Structure Infection
Conditions
Interventions
contezolid acefosamil
linezolid 600 mg
Locations
7
United States
MicuRx Site #106
Chula Vista, California, United States
MicuRx Site #103
La Mesa, California, United States
MicuRx Site #102
Long Beach, California, United States
MicuRx Site #104
Stockton, California, United States
MicuRx Site #107
Butte, Montana, United States
MicuRx Site #105
Las Vegas, Nevada, United States
Start Date
November 15, 2018
Primary Completion Date
March 26, 2019
Completion Date
March 26, 2019
Last Updated
November 8, 2022
NCT02979951
NCT05824988
NCT04911270
NCT03964493
NCT04847921
NCT00761215
Lead Sponsor
MicuRx
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions